Gilead Sciences, INC. (GILD) — SC 13G/A Filings

All SC 13G/A filings from Gilead Sciences, INC.. Browse 4 SC 13G/A reports with AI-powered summaries and risk analysis.

SC 13G/A Filings (4)

Vanguard Amends Gilead Sciences Stake, Holds 90.8M Shares — Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amendment (SC 13G/A) on February 13, 2024, updating its ownership in Gilead Sciences Inc. As of December 2
Gilead Sciences Updates Passive Stake in Tango Therapeutics — Feb 13, 2024 Risk: low
Gilead Sciences, Inc. filed an amended SC 13G/A on February 13, 2024, indicating its ownership of Tango Therapeutics, Inc. common stock as of December 31, 2023.
Capital World Investors Updates GILD Stake to 83.7M Shares — Feb 9, 2024 Risk: low
Capital World Investors, a major institutional investor, has updated its holdings in Gilead Sciences, Inc. (GILD) as of December 29, 2023. The filing shows they
BlackRock Amends Gilead Sciences Stake (13G/A) — Jan 24, 2024
BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating its ownership of Gilead Sciences Inc. common stock as of December 31, 2023. This

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX